GRCL:ADR (Sponsored)/Gracell Biotechnologies Inc - Stock Price Quote and Dividend Data
GRCL STOCK PRICE LATEST CLOSE
$10.25
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Biotechnology
ADR (Sponsored)/Gracell Biotechnologies Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
ADR (Sponsored)/Gracell Biotechnologies Inc Stock Price Information
52-Week Low/High Stock Price$1.40 - $10.44
Percent Held by Institutions44.54%
Revenue$57,000
Net Income$-599,842,000
Cash Flow$0
EPS-0.43%
Market Cap$0
PE Ratio to Industry57%
Debt-Equity Ratio9.62%
Debt-Equity to Industry1.43%
Total Return Last 12 Months409.95%
Total Return Last 3 Years-54.91%
Total Return Last 5 Years0.00%
Latest Trade DateFeb. 28, 2024
ADR (Sponsored)/Gracell Biotechnologies Inc Annual Stock Dividends
No Data available for Payment History.
ADR (Sponsored)/Gracell Biotechnologies Inc Dividend Payment History
| No dividends retrieved for GRCL |
ADR (Sponsored)/Gracell Biotechnologies Inc Other Dividend Details
Gracell Biotechnologies is a holding company. Through its subsidiaries, Co. engages in discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. Co.'s product candidates include: GC012F is a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate for the treatment of MM; GC019F is a FasTCAR-enabled CD19-directed autologous CAR-T product candidate for the treatment of adult B-ALL; GC027 is a TruUCAR-enabled CD7-directed allogeneic CAR-T product candidate for the treatment of adult T-ALL; and GC007g is a donor-derived CD19-directed allogeneic CAR-T cell therapy for the treatment of r/r B-ALL.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dec. 27, 2023GRCL STOCK PRICE INCREASE: ADR (Sponsored)/Gracell Biotechnologies Inc on 12-27-2023 increased stock price > 10% from $6.19 to $9.92
Dec. 13, 2023GRCL STOCK PRICE INCREASE: ADR (Sponsored)/Gracell Biotechnologies Inc on 12-13-2023 increased stock price > 10% from $4.87 to $5.41
Nov. 29, 2023GRCL STOCK PRICE DECREASE: ADR (Sponsored)/Gracell Biotechnologies Inc on 11-29-2023 decreased stock price > 10% from $5.40 to $4.50
Nov. 02, 2023GRCL STOCK PRICE INCREASE: ADR (Sponsored)/Gracell Biotechnologies Inc on 11-02-2023 increased stock price > 10% from $3.36 to $3.70
Oct. 03, 2023GRCL STOCK PRICE DECREASE: ADR (Sponsored)/Gracell Biotechnologies Inc on 10-03-2023 decreased stock price > 10% from $2.88 to $2.59
Aug. 08, 2023GRCL STOCK PRICE INCREASE: ADR (Sponsored)/Gracell Biotechnologies Inc on 08-08-2023 increased stock price > 10% from $3.42 to $3.83
Jul. 29, 2023GRCL STOCK PRICE INCREASE: ADR (Sponsored)/Gracell Biotechnologies Inc on 07-29-2023 increased stock price > 10% from $3.21 to $4.00
Jul. 28, 2023GRCL STOCK PRICE DECREASE: ADR (Sponsored)/Gracell Biotechnologies Inc on 07-28-2023 decreased stock price > 10% from $3.75 to $3.21
Jul. 06, 2023GRCL STOCK PRICE INCREASE: ADR (Sponsored)/Gracell Biotechnologies Inc on 07-06-2023 increased stock price > 10% from $3.84 to $4.23
Jul. 01, 2023GRCL STOCK PRICE INCREASE: ADR (Sponsored)/Gracell Biotechnologies Inc on 07-01-2023 increased stock price > 10% from $3.00 to $3.81
Apr. 09, 2025TCBPY STOCK PRICE DECREASE: TC BioPharm (Holdings) plc on 04-09-2025 decreased stock price > 10% from $0.40 to $0.27
Apr. 09, 2025MAZE STOCK PRICE DECREASE: Maze Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $8.92 to $7.57
Apr. 09, 2025KANT STOCK PRICE DECREASE: Kineta Inc on 04-09-2025 decreased stock price > 10% from $0.35 to $0.30
Apr. 09, 2025ORKA STOCK PRICE DECREASE: Oruka Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $7.62 to $6.78
Apr. 09, 2025XCUR STOCK PRICE DECREASE: Com Par $0.0001/Exicure Inc on 04-09-2025 decreased stock price > 10% from $12.80 to $11.39
Apr. 09, 2025BIVI STOCK PRICE DECREASE: Cl A Par $0.0001/BioVie Inc on 04-09-2025 decreased stock price > 10% from $0.80 to $0.71
Apr. 09, 2025ARTV STOCK PRICE DECREASE: Artiva Biotherapeutics Inc on 04-09-2025 decreased stock price > 10% from $3.31 to $1.92
Apr. 09, 2025ENTO STOCK PRICE DECREASE: Com Par $0.0001 (New)/Entero Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $0.49 to $0.42
Apr. 09, 2025APDN STOCK PRICE DECREASE: Com Par $0.001 (New)/Applied DNA Sciences Inc on 04-09-2025 decreased stock price > 10% from $1.30 to $1.13
Apr. 09, 2025RKVTF STOCK PRICE DECREASE: Rakovina Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $0.06 to $0.05
